Shah Smital's Form 4 filing
LENZ Therapeutics, Inc. (LENZ) · filed Jul 1, 2021
- Accession no.
- 0000899243-21-027014
- Filed
- Jul 1, 2021
- Trade date
- Apr 15-Jun 29, 2021
- Filing delay
- 77 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $100.0K. It was filed 77 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shah SmitalCIK 0001808821 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2021 | Common Stock | PPurchaseAcquired | +5,882 | $17.00 | +$99,994 | 5,882 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2021 | Common Stock | AGrant or awardAcquired | +93,585 | $0.00 | $0 | 93,585 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.